Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
Phillips also named President of Altemia & Co., a Lobe Sciences Company ... | June 7, 2023
Stay updated with breaking news from Baxter Phillips. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phillips also named President of Altemia & Co., a Lobe Sciences Company ... | June 7, 2023
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has appointed Baxter Phillips III to the newly created position of chief operating officer (COO) effective...
This gig at Koko in Camden Town saw the British four-piece rockers on riotously and irresistibly energetic form
Share: -Facility to supply drug product for planned Phase 3 clinical trials and early access programme Cambridge Allergy Ltd ("Camallergy" or "the Company"), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced that its manufacturing facility outside of Portsmouth, United Kingdom was approved by the MHRA, the Medicines and Healthcare products Regulatory Agency, to manufacture its proprietary peanut allergy treatment under current Good Manufacturing Practices (cGMP) standards. "This clearance is a pivotal...